(Q44375221)

2 December 2017

Serum tenascin-C level is associated with coronary plaque rupture in patients with acute coronary syndrome (English)

1 reference

2 December 2017

10

Hitoshi Suzuki

1 reference

2 December 2017

Nobuo Sakamoto

1

1 reference

2 December 2017

Yasuto Hoshino

2

1 reference

2 December 2017

Tomofumi Misaka

3

1 reference

2 December 2017

Hiroyuki Mizukami

4

1 reference

2 December 2017

Satoshi Suzuki

5

1 reference

2 December 2017

Koichi Sugimoto

6

1 reference

2 December 2017

Takayoshi Yamaki

7

1 reference

2 December 2017

Hiroyuki Kunii

8

1 reference

2 December 2017

Kazuhiko Nakazato

9

1 reference

2 December 2017

Shu-ichi Saitoh

11

1 reference

2 December 2017

Yasuchika Takeishi

12

1 reference

2 December 2017

27 March 2013

1 reference

2 December 2017

1 reference

2 December 2017

29

1 reference

2 December 2017

2

1 reference

2 December 2017

165-170

1 reference

https://scigraph.springernature.com/pub.10.1007/s00380-013-0341-2

2 December 2017

0 references

cites work

Advances in tenascin-C biology

1 reference

https://api.crossref.org/works/10.1007%2FS00380-013-0341-2

The role of tenascin-C in tissue injury and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-013-0341-2

Aortic smooth muscle cells interact with tenascin-C through its fibrinogen-like domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-013-0341-2

Molecules in focus: tenascin-C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-013-0341-2

Tenascin-C modulates adhesion of cardiomyocytes to extracellular matrix during tissue remodeling after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-013-0341-2

Tenascin-C is a useful marker for disease activity in myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-013-0341-2

Different susceptibility of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-013-0341-2

Expression and immune function of tenascin-C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-013-0341-2

Revised equations for estimated GFR from serum creatinine in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-013-0341-2

Tenascin-C is associated with coronary plaque instability in patients with acute coronary syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-013-0341-2

Detection of experimental autoimmune myocarditis in rats by 111In monoclonal antibody specific for tenascin-C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-013-0341-2

Tenascins: regulation and putative functions during pathological stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-013-0341-2

Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-013-0341-2

Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-013-0341-2

The pathogenesis of atherosclerosis (first of two parts)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-013-0341-2

Deletion of tenascin-C gene exacerbates atherosclerosis and induces intraplaque hemorrhage in Apo-E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-013-0341-2

Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture

21 January 2018

1 reference

12 December 2020

Tenascin-C is expressed in macrophage-rich human coronary atherosclerotic plaque

1 reference

12 December 2020

Induction of tenascin in rat arterial injury. Relationship to altered smooth muscle cell phenotype

1 reference

12 December 2020

Developmental changes in patterns of expression of tenascin-C variants in the human cornea.

1 reference

12 December 2020

Regression of hypertrophied rat pulmonary arteries in organ culture is associated with suppression of proteolytic activity, inhibition of tenascin-C, and smooth muscle cell apoptosis

1 reference

12 December 2020

Novel Function of Tenascin-C, a Matrix Protein Relevant to Atherosclerosis, in Platelet Recruitment and Activation Under Flow

1 reference

12 December 2020

Higher serum tenascin-C levels reflect the severity of heart failure, left ventricular dysfunction and remodeling in patients with dilated cardiomyopathy

1 reference

12 December 2020

Mast cell infiltration in acute coronary syndromes: implications for plaque rupture

1 reference

12 December 2020

Intravascular ultrasound appearance of scattered necrotic core as an index for deterioration of coronary flow during intervention in acute coronary syndrome

1 reference

12 December 2020

Serum tenascin-C might be a novel predictor of left ventricular remodeling and prognosis after acute myocardial infarction

1 reference

12 December 2020

Atherosclerotic plaque rupture and thrombosis. Evolving concepts

1 reference

12 December 2020

Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction

1 reference

12 December 2020

Intravascular ultrasound assessment of the association between spatial orientation of ruptured coronary plaques and remodeling morphology of culprit plaques in ST-elevation acute myocardial infarction

1 reference

12 December 2020

10.1007/S00380-013-0341-2

Identifiers

DOI

1 reference

2 December 2017

1 reference